Allison Carol Nugent

Allison Carol Nugent

Auto-generated profile, based on publicly available information

Allison Carol Nugent

Magnetoencephalography Core Facility, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2014 in Brain Imaging and Behavior
Verified
Journal Article
Open access
PDF file
PTPaul M. Thompson
Paul M. Thompson
JSJason L. Stein
Jason L. Stein
SMSarah E. Medland
Sarah E. Medland
DHDerrek P. Hibar
Derrek P. Hibar
AVAlejandro Arias Vasquez
Alejandro Arias Vasquez
WDWayne Drevets
Wayne Drevets
The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of large-scale studies that integrate data from 70 institutions worldwide. Organized into Working Groups that tackle questions in neuroscience, genetics, and medicine, ENIGMA studies have analyzed neuroimaging data from over 12,826 subjects. In addition, data from 12,171 individuals were provided by the CHARGE consortium for replication of findings, in a total of 24,997 subjects. By meta-analyzing results from many sites, ENIGMA has detected factors that affect the brain that no individual site could detect on its own, and that require larger numbers of subjects than any individual neuroimaging study has currently collected. ENIGMA’s first project was a genome-wide association study identifying common variants in the genome associated with hippocampal volume or intracranial volume. Continuing work is exploring genetic associations with subcortical volumes (ENIGMA2) and white matter microstructure (ENIGMA-DTI). Working groups also focus on understanding how schizophrenia, bipolar illness, major depression and attention deficit/hyperactivity disorder (ADHD) affect the brain. We review the current progress of the ENIGMA Consortium, along with challenges and unexpected discoveries made on the way.

15 April 2012 in Nature Genetics
Verified
Journal Article
Open access
PDF file
T(The Alzheimer'S Disease Neuroimaging Initiative (Adni)
The Alzheimer'S Disease Neuroimaging Initiative (Adni)
JSJason L Stein
Jason L Stein
ECEPIGEN Consortium
EPIGEN Consortium
ICIMAGEN Consortium
IMAGEN Consortium
S(Saguenay Youth Study Group (SYS)
Saguenay Youth Study Group (SYS)
PTPaul M. Thompson
Paul M. Thompson
Paul Thompson and colleagues report a genome-wide association study for hippocampal, intracranial and total brain volume. They identify a locus at 12q24 associated with hippocampal volume and a locus at 12q14 associated with intracranial volume. Identifying genetic variants influencing human brain structures may reveal new biological mechanisms underlying cognition and neuropsychiatric illness. The volume of the hippocampus is a biomarker of incipient Alzheimer's disease1,2 and is reduced in schizophrenia3, major depression4 and mesial temporal lobe epilepsy5. Whereas many brain imaging phenotypes are highly heritable6,7, identifying and replicating genetic influences has been difficult, as small effects and the high costs of magnetic resonance imaging (MRI) have led to underpowered studies. Here we report genome-wide association meta-analyses and replication for mean bilateral hippocampal, total brain and intracranial volumes from a large multinational consortium. The intergenic variant rs7294919 was associated with hippocampal volume (12q24.22; N = 21,151; P = 6.70 × 10−16) and the expression levels of the positional candidate gene TESC in brain tissue. Additionally, rs10784502, located within HMGA2, was associated with intracranial volume (12q14.3; N = 15,782; P = 1.12 × 10−12). We also identified a suggestive association with total brain volume at rs10494373 within DDR2 (1q23.3; N = 6,500; P = 5.81 × 10−7).

21 January 2004 in Journal of Neuroscience
Verified
Journal Article
Open access
ANAlexander Neumeister
Alexander Neumeister
EBEarle Bain
Earle Bain
ANAllison C. Nugent
Allison C. Nugent
RCRichard E. Carson
Richard E. Carson
OBOmer Bonne
Omer Bonne
WDWayne C. Drevets
Wayne C. Drevets
Recent animal models suggest that disturbances in serotonin type-1A receptor (5-HT1AR) function may contribute to chronic anxiety, although it is not clear at all whether such models constitute relevant models for panic disorder (PD) in humans. The selective 5-HT1AR radioligand [18F]trans-4-fluoro-N-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide (FCWAY) permitsin vivoassessment of central 5-HT1AR binding using positron emission tomography (PET). We studied 16 unmedicated symptomatic outpatients with PD and 15 matched healthy controls. Seven patients had an additional diagnosis of a current major depressive episode, however PD was the primary diagnosis. A 120 min PET study of 5-HT1AR binding was acquired using a GE Advance scanner in three-dimensional mode. Using quantitative PET image analysis, regional values were obtained for [18F]-FCWAY volume of distribution (DV), corrected for plasma protein binding, and K1, the delivery rate of [18F]-FCWAY from plasma to tissue. MRI scanning was performed using a GE Signa Scanner (3.0 Tesla) to provide an anatomical framework for image analysis and partial volume correction of PET data. PD patients showed lower DV in the anterior cingulate (t= 4.3;p< 0.001), posterior cingulate (t= 4.1;p< 0.001), and raphe (t= 3.1;p= 0.004). Comparing patients with PD, patients with PD and comorbid depression, and healthy controls revealed that DVs did not differ between PD patients and PD patients with comorbid depression, whereas both patient groups differed significantly from controls. These results provide for the first timein vivoevidence for the involvement of 5-HT1ARs in the pathophysiology of PD.

15 March 2012 in Bipolar Disorders
Verified
Journal Article
Closed access
PDF file
SSSudhakar Selvaraj
Sudhakar Selvaraj
Danilo ArnoneDanilo Arnone
Danilo Arnone
DJDominic Job
Dominic Job
ASAndrew Stanfield
Andrew Stanfield
TFTom Farrow
Tom Farrow
AMAndrew M McIntosh
Andrew M McIntosh

1 April 2005 in Biological Psychiatry
Verified
Journal Article
Closed access
ANAlexander Neumeister
Alexander Neumeister
SWSuzanne Wood
Suzanne Wood
OBOmer Bonne
Omer Bonne
ANAllison C. Nugent
Allison C. Nugent
DLDavid A. Luckenbaugh
David A. Luckenbaugh
WDWayne C. Drevets
Wayne C. Drevets

1 August 2004 in Archives of General Psychiatry
Verified
Journal Article
Closed access
PDF file
ANAlexander Neumeister
Alexander Neumeister
ANAllison C. Nugent
Allison C. Nugent
TWTracy Waldeck
Tracy Waldeck
MGMarilla Geraci
Marilla Geraci
MSMarkus Schwarz
Markus Schwarz
WDWayne C. Drevets
Wayne C. Drevets
Research from JAMA Psychiatry — Neural and Behavioral Responses to Tryptophan Depletion in UnmedicatedPatients With Remitted Major Depressive Disorder and Controls